Get the latest Science News and Discoveries

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds - EurekAlert!


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of NSCLC

NSCLC

Photo of Osimertinib

Osimertinib

Photo of EGFR

EGFR

Related news:

News photo

Dietary changes could provide a therapeutic avenue for brain cancer - EurekAlert!

News photo

This common fish has an uncommon feature: Forehead teeth, used for mating - EurekAlert!

News photo

Can the 'good' bacteria in your mouth act as probiotic cavity fighters? - EurekAlert!